JP2017526767A5 - - Google Patents

Download PDF

Info

Publication number
JP2017526767A5
JP2017526767A5 JP2017501288A JP2017501288A JP2017526767A5 JP 2017526767 A5 JP2017526767 A5 JP 2017526767A5 JP 2017501288 A JP2017501288 A JP 2017501288A JP 2017501288 A JP2017501288 A JP 2017501288A JP 2017526767 A5 JP2017526767 A5 JP 2017526767A5
Authority
JP
Japan
Prior art keywords
alkyl
cooh
cycloalkyl
substituted
heteroalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017501288A
Other languages
English (en)
Japanese (ja)
Other versions
JP6765363B2 (ja
JP2017526767A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/039881 external-priority patent/WO2016007821A2/en
Publication of JP2017526767A publication Critical patent/JP2017526767A/ja
Publication of JP2017526767A5 publication Critical patent/JP2017526767A5/ja
Application granted granted Critical
Publication of JP6765363B2 publication Critical patent/JP6765363B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017501288A 2014-07-11 2015-07-10 主鎖ポリアミン Expired - Fee Related JP6765363B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462023330P 2014-07-11 2014-07-11
US62/023,330 2014-07-11
PCT/US2015/039881 WO2016007821A2 (en) 2014-07-11 2015-07-10 Main chain polyamines

Publications (3)

Publication Number Publication Date
JP2017526767A JP2017526767A (ja) 2017-09-14
JP2017526767A5 true JP2017526767A5 (https=) 2018-08-09
JP6765363B2 JP6765363B2 (ja) 2020-10-07

Family

ID=53682888

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017501288A Expired - Fee Related JP6765363B2 (ja) 2014-07-11 2015-07-10 主鎖ポリアミン

Country Status (15)

Country Link
US (1) US20170182087A1 (https=)
EP (1) EP3189091A2 (https=)
JP (1) JP6765363B2 (https=)
KR (1) KR20170028979A (https=)
CN (1) CN106687504A (https=)
AR (1) AR101184A1 (https=)
AU (1) AU2015287661B2 (https=)
BR (1) BR112017000258A2 (https=)
CA (1) CA2954768A1 (https=)
IL (1) IL249963A0 (https=)
MX (1) MX2017000447A (https=)
RU (1) RU2017104223A (https=)
SG (1) SG11201610886VA (https=)
TW (1) TW201615694A (https=)
WO (1) WO2016007821A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10301254B2 (en) 2015-04-23 2019-05-28 Temple University—Of the Commonwealth System of Higher Education Substituted polycationic multi-quaternary ammonium salts as antimicrobial agents
US11111216B2 (en) 2016-10-26 2021-09-07 Temple University-Of The Commonwealth System Of Higher Education Polycationic amphiphiles as antimicrobial agents and methods using same
GB201700404D0 (en) * 2017-01-10 2017-02-22 Saraswati Res And Dev Inst Compounds and composistions
GB2584074B (en) 2019-04-16 2021-08-11 Alectrona Pte Ltd Monoterpene phenol derivatives

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790953A (fr) * 1971-11-05 1973-05-03 Beecham Group Ltd Matiere biologiquement active
BE793157A (fr) * 1971-12-21 1973-06-21 Beecham Group Ltd Substance antivirale
IT981412B (it) * 1973-03-15 1974-10-10 Montedison Spa Poliammidi da acidi eterociclici aromatici ortocarbossilici e pro cedimento per prepararle
US4013507A (en) * 1973-09-18 1977-03-22 California Institute Of Technology Ionene polymers for selectively inhibiting the vitro growth of malignant cells
USRE38417E1 (en) * 1986-12-02 2004-02-03 University Of Florida Research Foundation, Inc. Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
CA1305425C (en) * 1986-12-02 1992-07-21 Raymond J. Bergeron Anti-neoplastic spermine derivative
JPH02116843A (ja) * 1988-10-27 1990-05-01 Konica Corp 帯電防止されたハロゲン化銀写真感光材料
JP2847164B2 (ja) * 1989-05-19 1999-01-13 ダウコーニングアジア株式会社 繊維体用抗菌剤
DE10065710A1 (de) * 2000-12-29 2002-07-04 Bayer Ag Arzneimittel enthaltend ein Polyamin als Wirksubstanz
US6955806B2 (en) * 2001-01-18 2005-10-18 Genzyme Corporation Ionene polymers and their use as antimicrobial agents
WO2004046223A2 (en) * 2002-11-19 2004-06-03 Genzyme Corporation Polyionene polymers with hydrolyzable linkages
WO2004046109A2 (en) * 2002-11-19 2004-06-03 Genzyme Corporation Ionene oligomers and polymers
WO2004045629A1 (en) * 2002-11-19 2004-06-03 Genzyme Corporation Polyionenes for treating infections associated with cystic fibrosis
US20100197888A1 (en) * 2007-07-31 2010-08-05 Polyplus Transfection Method for Manufacturing Linear Polyethylenimine (PEI) for Transfection Purpose and Linear PEI Obtained with Such Method
WO2010044390A1 (ja) * 2008-10-14 2010-04-22 株式会社日本触媒 ポリアルキレンイミンを含むウイルス感染症治療薬
US8853457B2 (en) * 2010-01-04 2014-10-07 Rhodia Operations Polyamine and method for producing thereof
KR101291642B1 (ko) * 2010-03-03 2013-08-01 성균관대학교산학협력단 폴리(아미도 아민) 올리고머 하이드로젤 조성물 및 이를 이용한 약물전달체
NZ607000A (en) * 2010-08-24 2015-02-27 Imp Innovations Ltd Glycodendrimers of polypropyletherimine
MX373164B (es) * 2013-03-15 2020-05-07 Genzyme Corp Composiciones antimicrobianas de poliamida y tratamiento de mastitis.

Similar Documents

Publication Publication Date Title
JP2016514192A5 (https=)
JP2018021051A5 (https=)
JP2014500861A5 (https=)
JP2020097577A5 (https=)
JP2013534248A5 (https=)
JP2015537020A5 (https=)
JP2018533593A5 (https=)
JP2016534063A5 (https=)
JP2012072150A5 (https=)
JP2016513130A5 (https=)
JP2020507589A5 (https=)
JP2017526767A5 (https=)
JP2013542992A5 (https=)
RU2011136250A (ru) Низкомолекулярное полисульфатированное производное гиалуроновой кислоты и содержащее его лекарственное средство
JP2017523169A5 (https=)
JP2010527913A5 (https=)
JP2017531619A5 (https=)
JP2015522589A5 (https=)
JP2016522254A5 (https=)
JP2015051983A5 (https=)
JP2016510326A5 (https=)
JP2019535723A5 (https=)
JP2019516739A5 (https=)
RU2014109441A (ru) Амидные соединения, способы получения, применение в качестве средств для лечения и профилактики заболеваний, вызываемых рнк-содержащими вирусами
JP2019505529A5 (https=)